
Blebbistatin
CAS No. 674289-55-5
Blebbistatin( (±)-Blebbistatin )
Catalog No. M24685 CAS No. 674289-55-5
Blebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 40 | In Stock |
![]() ![]() |
5MG | 63 | In Stock |
![]() ![]() |
10MG | 120 | In Stock |
![]() ![]() |
25MG | 203 | In Stock |
![]() ![]() |
50MG | 357 | In Stock |
![]() ![]() |
100MG | 538 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBlebbistatin
-
NoteResearch use only, not for human use.
-
Brief DescriptionBlebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing.
-
DescriptionBlebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing. Furthermore it preserves cell junctional integrity and barrier function.
-
In Vitro——
-
In VivoAnimal Model:New Zealand white rabbits (16-20 weeks; 3-3.5 kg) Dosage:0.05 mL; 20 μM Administration:Intracameral injection; daily; for 6 days Result:Resulted in significant improvement of corneal clarity and corneal edema resolution, implying the restoration of an intact corneal endothelial monolayer.
-
Synonyms(±)-Blebbistatin
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
Recptornon-muscle myosin II ATPases
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number674289-55-5
-
Formula Weight292.33
-
Molecular FormulaC18H16N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 23 mg/mL (78.67 mM; Need ultrasonic)
-
SMILESCc(cc1)cc(C(C2(CC3)O)=O)c1N=C2N3c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ho WT, et al. Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamics. J Mol Med (Berl). 2019 Sep;97(9):1345-1357.
molnova catalog



related products
-
(S)-PF-03716556
(S)-PF-03716556 can be used as an acid pump inhibitor for the treatment of disease conditions mediated by acid pump inhibitory activity.
-
Sodium oleate
Sodium oleate (cis-9-Octadecenoic acid sodium salt) (Oleic acid sodium) is an abundant monounsaturated fatty acid sodium. Sodium oleate is a Na+/K+ ATPase activator.
-
Lanatoside C
Lanatoside C is a cardiac glycoside, a type of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat).